Press Releases | Medtronic

Month Year

Email alerts

Dec 8, 2020

Medtronic Launches the First and Only Pediatric and Neonatal Acute Dialysis Machine in the U.S.

The Carpediem™ system is designed to treat patients requiring renal replacement therapy weighing between 2.5 and 10 kilograms (5.5 to 22 pounds)

Medtronic plc (NYSE:MDT) today announced the U.S. commercial launch of the Carpediem™ Cardio-Renal Pediatric Dialysis Emergency Machine. Following the U.S. Food and Drug Administration's (FDA)...
- Photos 1
Dec 1, 2020

Medtronic SVP of Strategy Mike Weinstein to Speak at Evercore ISI Healthcare Conference

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Evercore ISI 3rd Annual HealthCONx Conference on Thursday, December 3, 2020....
Nov 30, 2020

Medtronic EVP & President of Cardiovascular Portfolio Mike Coyle to Speak at Piper Sandler Healthcare Conference

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Piper Sandler 32nd Annual Healthcare Conference on Wednesday, December 2,...
Nov 30, 2020

Medtronic and the Medtronic Foundation Expand COVID-19 Support to More Than $46 Million USD

- New Commitment Includes Nearly $4 Million for Health Workers, Mental Health, Food Assistance, and Critical Services in Black, Indigenous and People of Color (BIPOC) Communities

With the pandemic surging across the globe and food insecurity on the rise, Medtronic and the Medtronic Foundation today announced an additional $3.8 million commitment to provide healthcare...
Nov 24, 2020

Medtronic Reports Second Quarter Fiscal 2021 Financial Results

- Q2 Revenue of $7.6 Billion Decreased 0.8% Reported and 1.5% Organic - Q2 GAAP Diluted EPS of $0.36; Q2 Non-GAAP Diluted EPS of $1.02 DUBLIN, Nov. 24, 2020 /PRNewswire/ -- Medtronic plc...
Nov 17, 2020

Medtronic to Announce Financial Results for its Second Quarter of Fiscal Year 2021

Medtronic plc (NYSE:MDT) announced today that it will report financial results for its second quarter of fiscal year 2021 on Tuesday, November 24, 2020. A news release will be issued at...
Nov 16, 2020

The New England Journal of Medicine: Medtronic Cryoablation is a Superior Treatment Option for Symptomatic Paroxysmal Atrial Fibrillation Compared to Drug Therapy

Results from Three Studies Show Medtronic Cryoablation is Superior to Drug Therapy for First-Line Treatment

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the primary results of the Medtronic-sponsored STOP AF First clinical trial have been published in the New...
Nov 16, 2020

Medtronic Completes Acquisition of Medicrea

Acquisition Expands Medtronic's Artificial Intelligence and Data Capabilities, Becoming the First Company to Offer an Integrated Spine Solution Including AI-Driven Surgical Planning, Personalized...
Nov 13, 2020

Medtronic Ranked as a Leading Sustainability Company

Strong ESG Practices Results in Inclusion on North American Dow Jones Sustainability Index (DJSI) for 13th Consecutive Year

Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced that it has been recognized as one of the world's leading companies for sustainability with its inclusion in the...
Nov 12, 2020

Medtronic Launches InPen™ with Real-Time Guardian™ Connect CGM Data -- the First Integrated Smart Insulin Pen for People with Diabetes on MDI

Real-Time Glucose Data Coupled with InPen's Dose Calculator Helps Users Make Better Dosing Decisions

Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of InPen™ integrated with real-time1 Guardian Connect™ CGM data. InPen is the first and only...
Oct 29, 2020

Medtronic Expands ENT Portfolio with FDA Clearance of NIM Vital™ Next Generation Intraoperative Nerve Monitoring System and Acquisition of Ai Biomed Corp.

New Technologies Address Most Common Challenges During Head and Neck Surgery

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital™ nerve monitoring...
Oct 26, 2020

Medtronic Venous Stent Receives U.S. FDA Approval to Treat Venous Outflow Obstruction

Abre™ Venous Self-Expanding Stent System Safe, Effective in Treating Challenging Deep Venous Lesions

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for the Abre™ venous self-expanding stent...
Oct 20, 2020

Patients Report Superior, Sustained and Profound Back Pain Relief at 12 Months with DTM™ Spinal Cord Stimulation Therapy Using the Medtronic Intellis™ Platform

Study Reports 84% Back Pain Responder Rate and 69% Profound Responder Rate at 12 Months(1)

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced statistically significant 12-month results from a large, multicenter randomized controlled trial (RCT) that...
- Photos 1
Oct 18, 2020

Nine-Month Results from Medtronic IN.PACT BTK Study Presented in Late-Breaking Clinical Trial Sessions at TCT Connect Annual Meeting

Feasibility Study of Medtronic Drug-Coated Balloon Technology for Challenging Below-the-Knee Disease Shows Promise in Patients with Critical Limb Ischemia DUBLIN, Oct. 18, 2020 /PRNewswire/ --...
Oct 14, 2020

Medtronic Announces Partnership with The Foundry to Develop Innovative Mitral Valve Repair Technology

Half Moon Medical's Technology Now Ready for Evaluation in Early Feasibility Study DUBLIN, Oct. 14, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today...
Oct 14, 2020

Medtronic Named One of America's Most JUST Companies by Forbes and JUST Capital

Company Also Ranked #13 Last Month on Fortune's 2020 'Change the World' List

Medtronic plc (NYSE:MDT), the global leader in medical technology, has been named one of America's most JUST companies, ranking 29th overall on the 'Forbes JUST 100' list for 2021 and first in its...
Oct 14, 2020

Medtronic Launches Head-to-Head TAVR Study Comparing the Evolut™ TAVR Platform Against the Edwards SAPIEN Valve in Small Annulus Patients

Medtronic Also Begins Feasibility Study of Evolut TAVR System in Moderate and Asymptomatic Aortic Stenosis Patients DUBLIN, Oct. 14, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader...
Oct 14, 2020

Medtronic Outlines Growth Strategy at Biennial Investor Day

Company Raises Revenue Growth Outlook Highlights Deep and Broad Pipeline and Technology Platforms DUBLIN, Oct. 14, 2020 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical...
Oct 13, 2020

Medtronic 2020 Integrated Performance Report Shares Goal of Carbon Neutrality by FY30, Achievement of 100% Gender Pay Equity in the U.S., and Progress on COVID-19 Response

Report Outlines Environmental, Social, and Governance (ESG) Topics Critical to the Company and Its Stakeholders DUBLIN, Oct. 13, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today released its...
Oct 9, 2020

Medtronic Donates Nearly $1 Million in Personal Protective Equipment to International Medical Corps for COVID-19 Response Efforts

In Partnership with the Medtronic Foundation, More Than 400,000 KN95 Respirators and 1.1 Million Surgical Masks to be Distributed to Healthcare Facilities Across Continental U.S. and Puerto Rico

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has donated nearly $1 million worth of personal protective equipment (PPE) to relief organization...
Oct 7, 2020

Medtronic Announces Adaptix™ Interbody System, the First Navigated Titanium Cage with Titan nanoLOCK™ Surface Technology

A World's First That Combines Innovative Technologies: Titan nanoLOCK™ Surface Technology and Navigation

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. launch of Adaptix™ Interbody System, the first navigated titanium implant with Titan nanoLOCK™...
- Photos 2
Oct 6, 2020

Omar Ishrak to Retire as Medtronic Executive Chairman and Chairman of the Board; Geoff Martha to Succeed Ishrak as Chairman of the Board, Effective December 11, 2020

Medtronic plc (NYSE:MDT) today announced that Omar Ishrak has decided not to stand for re-election at the Annual General Meeting in December and will retire as Executive Chairman and Chairman of...
Oct 6, 2020

Medtronic Announces First Patient Implanted in ELITE Study of InterStim™ Micro

ELITE is the Only Study of a Rechargeable Sacral Neurostimulation System to Include All Four Indications, Including Fecal Incontinence, Which Affects Millions

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first patient was implanted in its ELITE study of the InterStim™ Micro system — the only study of a...
Oct 5, 2020

Medtronic Announces Virtual 2020 Institutional Investor and Analyst Event and Webcast

Medtronic plc (NYSE:MDT) announced today that the company will host its biennial Institutional Investor and Analyst Event on Wednesday, October 14, 2020, from 8:00 a.m. to approximately 2:00 p.m....
Oct 1, 2020

Medtronic Resolute Onyx™ Drug Eluting Stent (DES) First to Receive One-Month DAPT Labeling in the U.S. with Expanded Indication for High Bleeding Risk Patients

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual-antiplatelet therapy...

Show per page